Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
dc.contributor.author | Wang, Youjin | |
dc.contributor.author | Best, Ana | |
dc.contributor.author | Fernández Torrón, Roberto | |
dc.contributor.author | Alsaggaf, Rotana | |
dc.contributor.author | García Puga, Mikel | |
dc.contributor.author | Dagnall, Casey L. | |
dc.contributor.author | Hicks, Belynda | |
dc.contributor.author | Thompson, Mone’t | |
dc.contributor.author | Matheu Fernández, Ander | |
dc.contributor.author | Zulaica Ijurco, Miren | |
dc.contributor.author | Greene, Mark H. | |
dc.contributor.author | López de Munain Arregui, Adolfo José | |
dc.contributor.author | Gadalla, Shahinaz M. | |
dc.date.accessioned | 2020-03-12T09:46:35Z | |
dc.date.available | 2020-03-12T09:46:35Z | |
dc.date.issued | 2019-12 | |
dc.identifier.citation | Annals of Clinical and Translational Neurology 7(1) : 126-131 (2019) | es_ES |
dc.identifier.issn | 2328-9503 | |
dc.identifier.uri | http://hdl.handle.net/10810/42159 | |
dc.description.abstract | Myotonic dystrophy type I (DM1) is an autosomal dominant disease of which clinical manifestations resemble premature aging. We evaluated the contribution of telomere length in pathogenesis in 361 DM1 patients (12 with serial measurements) and 223 unaffected relative controls using qPCR assay. While no differences in baseline leukocyte relative telomere length (RTL) was noted, the data suggested an accelerated RTL attrition in DM1 (discovery cohort: T/S change/year = -0.013 in DM1 vs. -0.005 in controls, P = 0.04); similar trend was noted in validation cohort. Further investigations are needed to examine the role of TL in the pathophysiology of DM1. | es_ES |
dc.description.sponsorship | The study was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | oxidative stress | es_ES |
dc.subject | cancer-risk | es_ES |
dc.subject | ctg repeat | es_ES |
dc.subject | age | es_ES |
dc.title | Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.50954 | es_ES |
dc.identifier.doi | 10.1002/acn3.50954 | |
dc.departamentoes | Neurociencias | es_ES |
dc.departamentoeu | Neurozientziak | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.